FindTrial
Sign In

Curcumin for Wilson’s Disease treatment

Curcumin as an adjuvant treatment option in Wilsons disease - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/05/067717
Enrollment
40
Registered
2024-05-21
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E830- Disorders of copper metabolism Health Condition 2: E830- Disorders of copper metabolism Health Condition 3: G02- Meningitis in other infectious andparasitic diseases classified elsewhere

Interventions

None listed

Sponsors

Council of Scientific and Industrial Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All consecutive patients with diagnosis of Wilson’s disease

Exclusion criteria

Exclusion criteria: o pregnancy or breastfeeding o Patients having pre-existing cardiac diseases, associated with other diseases (i.e., RHD, Congenital heart disease). o Patient having decompensated cirrhosis. o Patients having severe neurological impairment.

Design outcomes

Primary

MeasureTime frame
Clinical, radiological and manual screeningTimepoint: 6 weeks—

Secondary

MeasureTime frame
Brain 1.5 Tesla MRI (T1, T2, FLAIR, DWI, ADC, SWI SEQUENCE), USG abdomen, pelvis, KUBTimepoint: baseline and post intervention—

Countries

India

Contacts

Public ContactDr Neetu Rani Dhiman

Department of Neurology, Institute of Medical Sciences, Banaras Hindu University

gyanpurineetu@gmail.com7880301002

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026